teva pharmaceuticals introduces the first generic glp-1 for weight loss Liraglutide (Victoza) Becomes Generic Receptor Agonist Teva wins FDA nod for
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Yang X., Feng P., Zhang X., Li D., Wang R., Ji C., et al
These medications delay gastric emptying (though this effect may diminish somewhat with chronic use), which prolongs the sensation of fullness after meals
Krog-Mikkelsen I, Sloth B, Dimitrov D, Tetens I, Bjrck I, Flint A, et al
Individuals who experience nausea from GLP-1 medications tend to be more common when first starting treatment or increasing the dosage
Hypersensitivity at the injection site, and anaphylaxis (serious allergic reaction) can also occur
